Heart Failure Hospitalization Risk Compared With Empagliflozin vs Other Glucose-Lowering Tx
The EMPRISE study assessed the efficacy and safety of empagliflozin use in approximately 500,000 adults with type 2 diabetes.
All articles by Brian Park, PharmD
Tarpeyo Now Available to Reduce Proteinuria in Primary IgA Nephropathy
To help patients gain access to treatment, Calliditas Therapeutics has launched a patient support program called Tarpeyo Touchpoints.
Apabetalone Gets Breakthrough Tx Designation for MACE Prevention
The FDA has granted Breakthrough Therapy designation to apabetalone (Resverlogix Corp) in combination with standard of care therapy, including high-intensity statins, for the secondary prevention of major adverse cardiac events (MACE) in patients with type 2 diabetes mellitus and recent acute coronary syndrome.
Investigational Drug for Non-Muscle Invasive Bladder Cancer Gets Breakthrough Status
N-803 is an IL-15 superagonist complex consisting of an IL-15 mutant bound to an IL-15 receptor α/IgG1 Fc fusion protein
Selective Estrogen Receptor Modulators May Be Effective for Male Infertility
Selective estrogen receptor modulators (SERMs) may be effective for treating male infertility, according to a recent systematic review and meta-analysis published in Expert Opinion on Pharmacotherapy. SERMs are compounds that exhibit tissue-selective estrogen receptor agonist and antagonist activity. Clomiphene citrate and tamoxifen are two agents commonly used for the off-label management of male infertility. To…
- Loading...
Loading...
Next post in Reproductive Medicine
Loading... 
Loading...